Abstract
ObjectiveTo evaluate the relative efficacy of programmed cell death 1 (PD-1) or programmed cell death ligand 1 (PD-L1) inhibitors versus conventional drugs in patients with cancer that were PD-L1 positive...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have